Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-03-25 Hadas Nicole R. See Remarks Purchase +3,500 $17.00 $60K 76,123
2014-03-25 Satter Muneer A Director Conversion +1,441,265 1,441,265
2014-03-25 Satter Muneer A Director Purchase +91,295 $17.00 $1.6M 1,532,560
2014-03-25 Satter Muneer A Director Conversion · Series B Convertible Preferred Stock −260,873 0
2014-03-25 Satter Muneer A Director Conversion · Series C Convertible Preferred Stock −525,021 0
2014-03-25 Butler John P. President and CEO Purchase +13,850 $17.00 $235K 13,850
2014-03-25 Amello Jason SVP, CFO & Treasurer Purchase +4,000 $17.00 $68K 4,000
2014-03-25 Novo A/S 10% owner Conversion +1,333,797 1,333,797
2014-03-25 Novo A/S 10% owner Purchase +182,590 $17.00 $3.1M 1,516,387
2014-03-25 Novo A/S 10% owner Conversion · SERIES C PREFERRED STOCK −714,285 0

Page 30 of 30 · 590 trades